Found: 14
Select item for more details and to access through your institution.
Artificial intelligence-based diagnosis of asbestosis: analysis of a database with applicants for asbestosis state aid.
- Published in:
- European Radiology, 2023, v. 33, n. 5, p. 3557, doi. 10.1007/s00330-022-09304-2
- By:
- Publication type:
- Article
Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 15, doi. 10.1007/s40265-021-01654-3
- By:
- Publication type:
- Article
Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 4, p. 669, doi. 10.1007/s11095-022-03244-8
- By:
- Publication type:
- Article
Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2013, v. 462, n. 5, p. 547, doi. 10.1007/s00428-013-1404-6
- By:
- Publication type:
- Article
Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 2, p. 1, doi. 10.1002/bmc.5277
- By:
- Publication type:
- Article
The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 467, doi. 10.1111/bcp.12159
- By:
- Publication type:
- Article
Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
- Published in:
- Head & Neck, 2009, v. 31, n. 2, p. 220, doi. 10.1002/hed.20952
- By:
- Publication type:
- Article
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof‐of‐concept study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 699, doi. 10.1111/bcp.15520
- By:
- Publication type:
- Article
Hyperhydration with cisplatin does not influence pemetrexed exposure.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 871, doi. 10.1111/bcp.15031
- By:
- Publication type:
- Article
The Effect of St John's Wort on the Pharmacokinetics of Docetaxel.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 1, p. 103, doi. 10.1007/s40262-013-0102-5
- By:
- Publication type:
- Article
Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 394, doi. 10.1002/cpt.1989
- By:
- Publication type:
- Article
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1
- By:
- Publication type:
- Article
Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 8, p. 1576, doi. 10.1002/ijc.33721
- By:
- Publication type:
- Article